1. RI UFLA
  2. Faculdade de Ciências da Saúde - FCS
  3. FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)
Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/41226
Registro completo de metadados
Campo DCValorIdioma
dc.creatorMa, Cuiqing-
dc.creatorSu, Shan-
dc.creatorWang, Jiachao-
dc.creatorWei, Lin-
dc.creatorDu, Lanying-
dc.creatorJiang, Shibo-
dc.date.accessioned2020-05-26T14:02:08Z-
dc.date.available2020-05-26T14:02:08Z-
dc.date.issued2020-05-
dc.identifier.citationMA, C. et al. From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development. Microbes and Infection, [S.l.], May 2020. No prelo.pt_BR
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1286457920300824pt_BR
dc.identifier.urihttp://repositorio.ufla.br/jspui/handle/1/41226-
dc.description.abstractThe global pandemic of COVID-19 caused by SARS-CoV-2 (also known as 2019-nCoV and HCoV-19) has posed serious threats to public health and economic stability worldwide, thus calling for development of vaccines against SARS-CoV-2 and other emerging and reemerging coronaviruses. Since SARS-CoV-2 and SARS-CoV have high similarity of their genomic sequences and share the same cellular receptor (ACE2), it is essential to learn the lessons and experiences from the development of SARS-CoV vaccines for the development of SARS-CoV-2 vaccines. In this review, we summarized the current knowledge on the advantages and disadvantages of the SARS-CoV vaccine candidates and prospected the strategies for the development of safe, effective and broad-spectrum coronavirus vaccines for prevention of infection by currently circulating SARS-CoV-2 and other emerging and reemerging coronaviruses that may cause future epidemics or pandemics.pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsrestrictAccesspt_BR
dc.sourceMicrobes and Infectionpt_BR
dc.subject2019-nCoVpt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus (SARS-CoV)pt_BR
dc.subjectVaccinept_BR
dc.subjectCross-protectionpt_BR
dc.titleFrom SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine developmentpt_BR
dc.typeArtigopt_BR
Aparece nas coleções:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Arquivos associados a este item:
Não existem arquivos associados a este item.
Mostrar registro simples do item Recomendar este item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.